Correlation Between Aldeyra and BioLineRx
Can any of the company-specific risk be diversified away by investing in both Aldeyra and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and BioLineRx, you can compare the effects of market volatilities on Aldeyra and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and BioLineRx.
Diversification Opportunities for Aldeyra and BioLineRx
Poor diversification
The 3 months correlation between Aldeyra and BioLineRx is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Aldeyra i.e., Aldeyra and BioLineRx go up and down completely randomly.
Pair Corralation between Aldeyra and BioLineRx
Given the investment horizon of 90 days Aldeyra is expected to generate 1.1 times more return on investment than BioLineRx. However, Aldeyra is 1.1 times more volatile than BioLineRx. It trades about 0.03 of its potential returns per unit of risk. BioLineRx is currently generating about 0.0 per unit of risk. If you would invest 622.00 in Aldeyra on September 5, 2024 and sell it today you would lose (148.00) from holding Aldeyra or give up 23.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Aldeyra vs. BioLineRx
Performance |
Timeline |
Aldeyra |
BioLineRx |
Aldeyra and BioLineRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aldeyra and BioLineRx
The main advantage of trading using opposite Aldeyra and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
BioLineRx vs. Candel Therapeutics | BioLineRx vs. Cingulate Warrants | BioLineRx vs. Unicycive Therapeutics | BioLineRx vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |